Encyclopedia of Molecular Pharmacology

Living Edition
| Editors: Stefan Offermanns, Walter Rosenthal


  • Thomas WorzfeldEmail author
Living reference work entry
DOI: https://doi.org/10.1007/978-3-030-21573-6_198-1


Plexins comprise an evolutionary conserved and widely expressed family of transmembrane proteins that serve as receptors for semaphorins. They regulate key cellular functions such as morphology, proliferation, differentiation, and migration and play a pivotal role in cell-cell communication. On the basis of homology, they are grouped into four subfamilies (A–D). Semaphorins are a large family of secreted and membrane-associated proteins. In the mammalian system, five structurally different classes of semaphorins (3–7) have been found (Fig. 1). While the semaphorin-plexin system was initially discovered as a regulator of axonal guidance in the developing nervous system, it has become clear that its physiological and pathophysiological relevance is much larger including the cardiovascular, immune, renal, and bone system as well as cancer (Worzfeld and Offermanns 2014).
This is a preview of subscription content, log in to check access.


  1. Corà D, Astanina E, Giraudo E, Bussolino F (2014) Semaphorins in cardiovascular medicine. Trends Mol Med 20:589–598CrossRefGoogle Scholar
  2. Gurrapu S, Tamagnone L (2019) Semaphorins as regulators of phenotypic plasticity and functional reprogramming of cancer cells. Trends Mol Med 25:303–314CrossRefGoogle Scholar
  3. Jongbloets BC, Pasterkamp RJ (2014) Semaphorin signalling during development. Development 141:3292–3297CrossRefGoogle Scholar
  4. Koropouli E, Kolodkin AL (2014) Semaphorins and the dynamic regulation of synapse assembly, refinement, and function. Curr Opin Neurobiol 27:1–7CrossRefGoogle Scholar
  5. Nishide M, Kumanogoh A (2018) The role of semaphorins in immune responses and autoimmune rheumatic diseases. Nat Rev Rheumatol 14:19–31CrossRefGoogle Scholar
  6. Pascoe HG, Wang Y, Zhang X (2015) Structural mechanisms of plexin signaling. Prog Biophys Mol Biol 118:161–168CrossRefGoogle Scholar
  7. Van Battum EY, Brignani S, Pasterkamp RJ (2015) Axon guidance proteins in neurological disorders. Lancet Neurol 14:532–546CrossRefGoogle Scholar
  8. Verlinden L, Vanderschueren D, Verstuyf A (2016) Semaphorin signaling in bone. Mol Cell Endocrinol 432:66–74CrossRefGoogle Scholar
  9. Worzfeld T, Offermanns S (2014) Semaphorins and plexins as therapeutic targets. Nat Rev Drug Discov 13:603–621CrossRefGoogle Scholar
  10. Xia J, Worzfeld T (2016) Semaphorins and plexins in kidney disease. Nephron 132:93–100CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg New York 2020

Authors and Affiliations

  1. 1.Institute of PharmacologyUniversity of MarburgMarburgGermany
  2. 2.Department of PharmacologyMax-Planck-Institute for Heart and Lung ResearchBad NauheimGermany